[1] Vagios S,Hesham H .2020 .Understanding the potential of lactobacilli in recurrent UTI prevention. Microb Pathog, 148 : 104544.
[2] Pramanik S,Venkatraman S,Karthik P,Vaidyanathan VK .2023 .A systematic review on selection characterization and implementation of probiotics in human health. Food Sci Biotechnol, 32(4) : 423-40.
[3] Qasemi A,Lagzian M,Rahimi F,Majd FK,Bayat Z. .2023 .2(1):1. RBES, 2 : 01.
[4] Sadeghi-Bojd S,Naghshizadian R,Mazaheri M,Ghane Sharbaf F .2020 .Efficacy of probiotic prophylaxis after the first febrile urinary tract infection in children with normal urinary tracts. JPIDS, 9(3) : 305-10.
[5] Gupta V,Mastromarino P,Garg R .2023 .Effectiveness of prophylactic oral and/or vaginal probiotic supplementation in the prevention of recurrent urinary tract infections: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis, 75(5) : 1154-61.
[6] Emami E,Mt Sherwin C .2024 .Heidari-Soureshjani S. Effect of probiotics on urinary tract infections in children: a systematic review and meta-analysis. Curr Rev Clin Exp Pharmacol, 19(1) : 111-21.
[7] New FJ,Theivendrampillai S,Juliebø-Jones P,Somani B,Kurniawati EM,Hardianto G,Hadi TH,Paraton H,Widyasari A,Rahmawati NA .2023 .The role of probiotics in urinary tract infections in women. Indonesian J Obstet Gynecol, 11(3) : 189-97.
[8] Chen MJ,Chen CC,Huang YC,Tseng CC,Hsu JT,Lin YF .2021 .Taiwan gastrointestinal disease, Helicobacter consortium. The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota - a double-blind, placebo-controlled, randomized trial. Helicobacter, 26(6) : .
[9] Abdullatif VA,Sur RL,Eshaghian E,Gaura KA,Goldman B,Panchatsharam PK .2021 .Efficacy of probiotics as prophylaxis for urinary tract infections in premenopausal women: a systematic review and meta-analysis. Cureus, 13(10) : .
[10] Matuszkiewicz-Rowińska J,Małyszko J,Wieliczko M. .2013 .State of the art paper urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems. Arch Med Sci, 11(1) : 67-77.
[11] Kaur R,Kaur R.,Symptoms R. .2021 .risk factors, diagnosis and treatment of urinary tract infections. -139090, 97(1154) : 803-12.
[12] Zhao F,Yang H,Bi D,Khaledi A,Qiao M. .2020 .A systematic review and meta-analysis of antibiotic resistance patterns, and the correlation between biofilm formation with virulence factors in uropathogenic E. coli isolated from urinary tract infections. Microb Pathog, 144(11) : 104196.
[13] Chu CM,Lowder JL .2017 .Diagnosis and treatment of urinary tract infections across age groups. Am J Obstet Gynecol, 12(1) : 40-51.
[14] Fernández Suárez,Ridao Cano ML,Álvarez Santamarta N,Gago Fraile L,Blake M,Díaz Corte C. O .2021 .A current review of the etiology, clinical features, and diagnosis of urinary tract infection in renal transplant patients. Diagnostics, 11(8) : 1456.
[15] Sekharan CB,Kumari KR,Kuwingwa EE,Kumar DD .2017 .Evaluation of the prevalence of urinary tract infection in females aged 6-50 years at Kinondoni District, Tanzania. Sci Int, 42(2) : 42-6.
[16] Sangeda RZ,Paul F,Mtweve DM .2021 .Prevalence of urinary tract infections and antibiogram of uropathogens isolated from children under five attending Bagamoyo District Hospital in Tanzania: a cross-sectional study. F1000Res, 10 : 449.
[17] Salari N,Khoshbakht Y,Hemmati M,Khodayari Y,Khaleghi AA,Jafari F .2023 .Global prevalence of urinary tract infection in pregnant mothers: a systematic review and meta-analysis. Public Health, 08(4) : 58-65.
[18] Mann R,Mediati DG,Duggin IG,Harry EJ,Bottomley AL .2017 .Metabolic adaptations of uropathogenic E. coli in the urinary tract. Front Cell Infect Microbiol, 7 : 241.
[19] Mlugu EM,Mohamedi JA,Sangeda RZ,Mwambete KD .2023 .Prevalence of urinary tract infection and antimicrobial resistance patterns of uropathogens with biofilm forming capacity among outpatients in morogoro, Tanzania: a crosssectional study. BMC Infect Dis, 23(1) : 660.